For years, researchers have questioned whether hormone treatment (HT) is associated with an increased risk of gastroesophageal reflux disease (GERD). A recent systematic study and meta-analysis seek to settle the debate, indicating a strong link between ever or present HT usage and GERD.
A small study of couples facing unexplained infertility reveals that hormone therapy may boost the chances of having a baby.
The trial, presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1], compared couples trying to co
Following promising results from pre-clinical research and a recent clinical study on stem cell-based therapies for Type 1 diabetes patients, researchers are now focusing on maximising the function and potential of stem cell-based treatments for future patient application.
According to a new study, older female mice had more immune cells entering areas of the body where they shouldn't, demonstrating that gender differences contribute to age-related inflammation and should be included in future research.
According to research, women aged 45 and more who used oestrogen hormone treatment in tablet form were more likely to develop high blood pressure than those who used transdermal (topically applied to the skin) or vaginal formulations.
A study found that patients with early hormone-receptor (HR) positive/HER2 negative breast cancer had a significant advantage in invasive disease-free survival when ribociclib, a targeted therapy medicine, was added to hormone treatment.
A study discovered that when ribociclib, a targeted therapy medicine, is added to hormone treatment, patients with early hormone-receptor (HR) positive/HER2 negative breast cancer had a substantial invasive disease-free survival advantage.
A potential strategy for treating diabetes uses stem cells from the human stomach to create cells that release insulin in response to rising blood sugar levels.
As the population ages, there is a growing emphasis on bone health and fracture prevention in order to retain mobility. According to a new study, several forms of hormone therapy boost lumbar spine bone mineral density (BMD) in postmenopausal women and protect against bone loss even when hor
In many nations today, 50 per cent of the population is overweight, and the percentage is rising. Many people are successful in losing weight. Maintaining weight loss is the difficult part.
he results, published in JAMA Neurology, indicate that early age at menopause may be a risk factor for AD dementia, but that women who were prescribed HT around the age of menopause onset did not show increased risk.
Short-term menopause symptoms like hot flashes, which are brought on by variations in reproductive hormones, are well-known to many people. They might not be aware, however, that over time, menopause may compromise the health of the heart and the brain.